Vasopressin Receptor
Vasopressin receptors are G-protein coupled receptors that mediate coagulation factor release, platelet aggregation, vasoconstriction, release of antidiuresis and ACTH release etc.
Products Related to Vasopressin Receptor(34)
- GC12627Conivaptan HClCAS: 168626-94-6Purity: >99.50%
Conivaptan HCl is an orally active vasopressin receptor (V1a/V2; K i =0.48nM/3.04nM) antagonist.
- GA20807Big Endothelin-1 (1-38), humanCAS: 120796-97-6Purity: >98%
Big Endothelin-1 (1-38), human is the precursor of endothelin-1.
- GA20808Big Endothelin-1 (1-39), porcineCAS: 120796-99-8Purity: >98%
Big Endothelin-1 (1-39), porcine is the precursor of endothelin-1.
- GC11265Desmopressin AcetateCAS: 62288-83-9Purity: >98.00%
Desmopressin Acetate (DDAVP), a synthetic peptide analog of vasopressin, is a safe antidiuretic and hemostatic compound that acts as a selective agonist at the vasopressin V2 membrane receptor (V2R).
- GC16591d[Cha4]-AVPCAS: 500170-27-4Purity: >98%
d[Cha4]-AVPis a potent and selective Vasopressin (AVP) V1b receptor agonist with a K i value of 1.2nM, 151nM for V1b and V1a receptors, respectively.
- GC30764Argipressin (Vasopressin)CAS: 113-79-1Purity: >99.50%
Argipressin (Vasopressin), as an important hormone in the regulation of plasma osmolality and blood volume/pressure, always is used in the treatment of septic shock and decompensated cirrhosis.
- GC30890RG7713 (RO5028442)CAS: 920022-47-5Purity: >99.50%
RG7713 (RO5028442) (RO5028442) is a highly potent and selective Brain-Penetrant Vasopressin 1a (V1a) receptor antagonist with Kis of 1 nM (hV1a) and 39 nM (mV1a).
- GC31295Balovaptan (RG7314)CAS: 1228088-30-9Purity: >99.00%
Balovaptan (RG7314) is a novel, orally active, selective, and blood-brain barrier-penetrating vasopressin 1a (V1a) receptor antagonist.
- GC31475WAY-151932 (VNA-932)CAS: 220460-92-4Purity: >99.00%
WAY-151932 (VNA-932) is a vasopressin V2-receptor agonist with IC50 of 80.3 nM and 778 nM in human-V2 binding and V1a binding assay.
- GC32453Lixivaptan (VPA-985)CAS: 168079-32-1Purity: >99.50%
Lixivaptan (VPA-985) (VPA-985, WAY-VPA 985) is an orally active and selective vasopressin receptor V2 antagonist, with IC50 values of 1.2 and 2.3 nM for human and rat V2, respectively.
- GC32463TerlipressinCAS: 14636-12-5Purity: >98%
Terlipressin is a vasopressin analogue with potent vasoactive properties.
- GC39849Atosiban acetateCAS: 914453-95-5Purity: >99.50%
Atosiban acetate (RW22164 acetate;RWJ22164 acetate) is a nonapeptide competitive vasopressin/oxytocin receptor antagonist, and is a desamino-oxytocin analogue.
- GC44247Mozavaptan (hydrochloride)CAS: 138470-70-9Purity: >98.00%
Mozavaptan is a benzazepine derivative that antagonizes the binding of arginine vasopressin (AVP) to vasopressin receptors located in the liver (V1; IC50 = 1.2 μM) and kidney (V2; IC50 = 14 nM).
- GC50246TASP 0390325CAS: 1642187-96-9Purity: >98.00%
Potent and selective V1B receptor antagonist; orally bioavailable
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC12194 | Atosiban | 90779-69-4 | >99.00% | |
Atosiban is a mixed antagonist of oxytocin and vasopressin receptors. It effectively inhibits uterine contractions and prolongs pregnancy by competitively blocking oxytocin receptors on uterine smooth muscle. | ||||
| GC12627 | Conivaptan HCl | 168626-94-6 | >99.50% | |
Conivaptan HCl is an orally active vasopressin receptor (V1a/V2; K i =0.48nM/3.04nM) antagonist. | ||||
| GC14880 | Mozavaptan | 137975-06-5 | >98.00% | |
novel competitive vasopressin receptor antagonist | ||||
| GC15575 | Tolvaptan | 150683-30-0 | >98.00% | |
AVP V2-receptor antagonist | ||||
| GA20807 | Big Endothelin-1 (1-38), human | 120796-97-6 | >98% | |
Big Endothelin-1 (1-38), human is the precursor of endothelin-1. | ||||
| GA20808 | Big Endothelin-1 (1-39), porcine | 120796-99-8 | >98% | |
Big Endothelin-1 (1-39), porcine is the precursor of endothelin-1. | ||||
| GC10622 | OPC 21268 | 131631-89-5 | >98.00% | |
OPC 21268 is an orally effective, nonpeptide, vasopressin V1 receptor antagonist with an IC 50 of 0.4μM. | ||||
| GC11265 | Desmopressin Acetate | 62288-83-9 | >98.00% | |
Desmopressin Acetate (DDAVP), a synthetic peptide analog of vasopressin, is a safe antidiuretic and hemostatic compound that acts as a selective agonist at the vasopressin V2 membrane receptor (V2R). | ||||
| GC11991 | L-371,257 | 162042-44-6 | >99.00% | |
human oxytocin (OT) receptor antagonist | ||||
| GC12303 | Desmopressin | 16679-58-6 | >98.00% | |
A vasopressin receptor agonist | ||||
| GC12462 | SR 49059 | 150375-75-0 | >97.00% | |
vasopressin V1A receptor antagonist | ||||
| GC15154 | d[Leu4,Lys8]-VP | 42061-33-6 | >98% | |
Selective vasopressin V1B receptor agonist | ||||
| GC16591 | d[Cha4]-AVP | 500170-27-4 | >98% | |
d[Cha4]-AVPis a potent and selective Vasopressin (AVP) V1b receptor agonist with a K i value of 1.2nM, 151nM for V1b and V1a receptors, respectively. | ||||
| GC30764 | Argipressin (Vasopressin) | 113-79-1 | >99.50% | |
Argipressin (Vasopressin), as an important hormone in the regulation of plasma osmolality and blood volume/pressure, always is used in the treatment of septic shock and decompensated cirrhosis. | ||||
| GC30890 | RG7713 (RO5028442) | 920022-47-5 | >99.50% | |
RG7713 (RO5028442) (RO5028442) is a highly potent and selective Brain-Penetrant Vasopressin 1a (V1a) receptor antagonist with Kis of 1 nM (hV1a) and 39 nM (mV1a). | ||||
| GC31295 | Balovaptan (RG7314) | 1228088-30-9 | >99.00% | |
Balovaptan (RG7314) is a novel, orally active, selective, and blood-brain barrier-penetrating vasopressin 1a (V1a) receptor antagonist. | ||||
| GC31475 | WAY-151932 (VNA-932) | 220460-92-4 | >99.00% | |
WAY-151932 (VNA-932) is a vasopressin V2-receptor agonist with IC50 of 80.3 nM and 778 nM in human-V2 binding and V1a binding assay. | ||||
| GC32453 | Lixivaptan (VPA-985) | 168079-32-1 | >99.50% | |
Lixivaptan (VPA-985) (VPA-985, WAY-VPA 985) is an orally active and selective vasopressin receptor V2 antagonist, with IC50 values of 1.2 and 2.3 nM for human and rat V2, respectively. | ||||
| GC32463 | Terlipressin | 14636-12-5 | >98% | |
Terlipressin is a vasopressin analogue with potent vasoactive properties. | ||||
| GC38948 | SRX246 | 512784-93-9 | >98.50% | |
SRX246 is a centrally penetrant vasopressin 1a (V1a) receptor antagonist. | ||||
| GC39830 | Terlipressin acetate | 914453-96-6 | >99.50% | |
A prodrug form of lysipressin | ||||
| GC39849 | Atosiban acetate | 914453-95-5 | >99.50% | |
Atosiban acetate (RW22164 acetate;RWJ22164 acetate) is a nonapeptide competitive vasopressin/oxytocin receptor antagonist, and is a desamino-oxytocin analogue. | ||||
| GC44247 | Mozavaptan (hydrochloride) | 138470-70-9 | >98.00% | |
Mozavaptan is a benzazepine derivative that antagonizes the binding of arginine vasopressin (AVP) to vasopressin receptors located in the liver (V1; IC50 = 1.2 μM) and kidney (V2; IC50 = 14 nM). | ||||
| GC50246 | TASP 0390325 | 1642187-96-9 | >98.00% | |
Potent and selective V1B receptor antagonist; orally bioavailable | ||||